Search
Search Results
##search.searchResults.foundPlural##
-
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1931PDF: 966HTML: 1572 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9562PDF: 6330HTML: 88326Fig.1b: 294Fig.1c: 301Fig.2a: 291Fig.2b: 265Fig.4: 310Fig.2c: 274Fig.3: 281Tab.1: 342Tab.2: 314Tab.3: 300Tab.4: 340Fig1a: 291 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4486PDF: 2054HTML: 5565Table 1: 299 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3607PDF: 1621HTML: 5983Fig1-Ag-Pil: 287Ag-Pil Fig.2: 288 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1461PDF: 506HTML: 18641Figure 1: 207Figure 2: 191Figure 3: 206Figure 4: 244Figure 5: 212 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1329PDF: 822Html: 129 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
2000PDF: 1156HTML: 313 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3987PDF: 1691HTML: 8265Randi Fig: 235 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3308PDF: 966HTML: 7322Kost Fig1: 233Kost Fig 2: 220Kost Fig3: 234Kost Fig 4: 245Kost Fig5: 243Kost fig 6: 230 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1745PDF: 1205HTML: 278 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1313PDF: 655HTML: 6941 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2534PDF: 1986HTML: 190 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3650PDF: 2378HTML: 23649Untitled: 320Untitled: 297Untitled: 313 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3367PDF: 1441HTML: 4167 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3324PDF: 1709HTML: 408 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1291PDF: 894HTML: 3426 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1272PDF: 530HTML: 294 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4579PDF: 1000HTML: 1374Table1: 284 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1080PDF: 612HTML: 2234Cover Letter: 245 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13040PDF: 1781HTML: 4375Cover letter: 287Figure 1: 298 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2806PDF: 1272HTML: 292







